References
- Antiarrhythmics versus Implantable Defibrillators (AVID)
Investigators. A comparison of antiarrhythmic-drug therapy with
implantable defibrillators in patients resuscitated from near-fatal
ventricular arrhythmias. N Engl J Med 1997;337:1576–1583.
- Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an
implanted defibrillator in patients with coronary disease at high risk
for ventricular arrhythmia. Multicenter Automatic Defibrillator
Implantation Trial Investigators. N Engl J Med 1996;335:1933–1940.
- Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a
defibrillator in patients with myocardial infarction and reduced
ejection fraction. N Engl J Med 2002;346:877–883.
- Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A
randomized study of the prevention of sudden death in patients with
coronary artery disease. Multicenter Unsustained Tachycardia Trial
Investigators. N Engl J Med 1999;341:1882–1890.
- Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of
defibrillator shocks in patients with heart failure. N Engl J Med
2008;359:1009–1017.
- Sweeney MO, Sherfesee L, DeGroot PJ, Wathen MS, Wilkoff BL.
Differences in effects of electrical therapy type for ventricular
arrhythmias on mortality in implantable cardioverter-defibrillator
patients. Heart Rhythm 2010;7:353–360.
- Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized
multicenter trial of empirical antitachycardia pacing versus shocks
for spontaneous rapid ventricular tachycardia in patients with
implantable cardioverter-defibrillators: Pacing Fast Ventricular
Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
Circulation 2004;110:2591–2596.
- Anguera I, Dallaglio P, Martínez-Ferrer J, et al. Shock reduction with
multiple bursts of antitachycardia pacing therapies to treat fast
ventricular tachyarrhythmia in patients with implantable cardioverter
defibrillators: A multicenter study. J Cardiovasc Electrophysiol
2015;26:774–782.
- Sanders P, Connolly AT, Nabutovsky Y, Fischer A, Saeed M. Increased
hospitalizations and overall healthcare utilization in patients
receiving implantable cardioverter-defibrillator shocks compared with
antitachycardia pacing. J Am Coll Cardiol EP 2018;4:243–253.
- Gulizia MM, Piraino L, Scherillo M, et al. A randomized study to
compare ramp versus burst antitachycardia pacing therapies to treat
fast ventricular tachyarrhythmia in patients with implantable
cardioverter defibrillators: The PITAGORA ICD trial. Circ Arrhythm
Electrophysiol 2009;2:146–153.
- Fang Y, Gu K, Yang B, et al. What factors lead to the acceleration of
ventricular tachycardia during antitachycardia pacing?-Results from
over 1000 episodes. J Arrhythm 2017;34:36–45.
- Garcia-Alberola A, Yli-Mäyry S, Block M, et al. RR interval
variability in irregular monomorphic ventricular tachycardia and
atrial fibrillation. Circulation 1996;93:295–300.
- Oginosawa Y, Kohno R, Honda T, et al. Superior rhythm discrimination
with the SmartShock technology algorithm - results of the implantable
Defibrillator With Enhanced Features and Settings for Reduction of
Inaccurate Detection (DEFENSE) Trial. Circ J 2017;81:1272–1277.
- Duncker D, Veltmann C. Optimizing antitachycardia pacing: back to the
roots. Circ Arrhythm Electrophysiol 2017;10: number 9.
- Riley MP, Marchlinski FE. ECG clues for diagnosing ventricular
tachycardia mechanism. J Cardiovasc Electrophysiol 2008;19:224-229.
- Jiménez-Candil J, Hernández J, Martin A, et al. Influence of cycle
length variations on antitachycardia pacing effectiveness among ICD
patients. Heart Rhythm 2013;10:207–213.
- Tuan TC, Lo MT, Lin YJ, et al. The use of signal analyses of
ventricular tachycardia electrograms to predict the response of
antitachycardia pacing in patients with implantable
cardioverter-defibrillators. J Cardiovasc Electrophysiol
2014;25:411–417.
- Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert
consensus statement on catheter ablation of ventricular arrhythmias.
Heart Rhythm 2020;17:e2–154.
- Joung B, Lexcen DR, Ching CK, et al. Additional antitachycardia pacing
programming strategies further reduce unnecessary implantable
cardioverter-defibrillator shocks. Heart Rhythm 2020; 7:98–105.
- Cantillon DJ, Wilkoff BL. Antitachycardia pacing for reduction of
implantable cardioverter-defibrillator shocks. Heart Rhythm
2015;12:1370–1375.
- Josephson M. Evaluation of electrical therapy for arrhythmias. In:
Josephson M, editor. Clinical Cardiac Electrophysiology. Philadelphia,
PA: Lippincott Williams & Wilkins, 2008:701.
- Moak JP, Rosen MR. Induction and termination of triggered activity by
pacing in isolated canine Purkinje fibers. Circulation
1984;69:149–162.
- Kumar S, Romero J, Mehta NK, et al. Long-term outcomes after catheter
ablation of ventricular tachycardia in patients with and without
structural heart disease. Heart Rhythm 2016;13:1957–1963.